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Particle research and particle toxicology have been histor-
ically closely connected to industrial activities or materi-
als, such as coal, asbestos and manmade mineral fibers.
Until the early nineties papers on these icons of exposure
dominated the literature in classical journals with a strong
occupational or hygiene approach. Along with the evolu-
tion in our understanding of general disease, particle tox-
icology has benefited from the developments in
molecular medicine. Over time there has been a consider-
able change in the experimental approach taken by parti-
cle toxicologists. Nowadays inflammation as a key
response to particle deposition in tissue and a process in
particle effects has been inexorable and inflammation
now lies at the very heart of our understanding of lung
and systemic disease associated with particle exposure. As
in all molecular medicine, there has been a huge concen-
tration on the regulation of gene expression as a basis for
disease, and this continues. Oxidative stress has emerged
as the dominant paradigm for how particles initiate
inflammation and genotoxicity, a stress further aug-
mented by inflammatory cells releasing their arsenal of
oxidants.
Between 1995 and 2005, the health effects of ambient
particulate matter and explanations for their effects have
dominated research meetings and journals. Ambient par-
ticles suddenly were responsible for effects not only in the
lung, but also in the heart, the vascular system and
recently also the brain [1,2]. A new age of interaction with
other disciplines and clinical specialties was started. With
these changing targets and approaches also the array of
journals available for publication expanded, and interest-
ingly particle-induced effects have reached the forefront of
the general medical journals, as well the specialty journals
on lung, heart and other diseases. Particle research has
reached a professional quality and impact it has never
seen before.
Particle and Fibre Toxicology was started in 2004 at the very
summit of this interaction, and has published articles on
a variety of toxicological endpoints and mechanisms asso-
ciated to particles. A total of 45 was articles were pub-
lished in four years, on a variety of particles. About half of
the articles covered particles such as asbestos, quartz, die-
sel or ambient particle matter. Although the number of
manuscripts was rather low over the total period, the cita-
tion data based on Scopus data [3] showed 250 cites on
the first 40 articles. Based on this data, if the journal was
to receive an impact factor for 2007 (based on 2007 cita-
tions to 2005 and 2006 articles) this would be in the
region of 5.7. The high number of citations is in part
driven by a number of review articles concerning the
effects of nanomaterials and combustion nanoparticles
[2,4-6]. In addition, the fact that Particle and Fibre Toxicol-
ogy is the only journal on this topic which is free access
and online, has contributed extensively on its use and
citation in many other journals and reports.
The journal wants to play a decisive role in a decade where
particle research will be challenged and driven by the
developments and applications of nanomaterials. Already
more than 40% of articles in Particle and Fibre Toxicology
since the start of the journal in late 2004 were on this
topic, and we want to stimulate the interaction of produc-
ers, users and testers of nanomaterials in a variety of fields.
They are used in new polymers, so-called nanocomposites
and coatings, but also in drug delivery as well as medical
imaging through MRI and fluorescence. Most of these
applications and particles are new to the field, and we
have only started to understand how surface and its chem-
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ical properties do determine their aptness for interaction
with biological targets. However, studies have demon-
strated that even inert materials like gold and TiO2 in
nanosize can become chemically active. In other words,
inert materials can become reactive just by making them
smaller.
Nowadays nanoparticles are generated from highly skilled
research labs and produced for many applications and in
many countries. In the near future upscaling of produc-
tion is expected and worker exposure and consumer con-
tact are expected to increase dramatically over the years to
come. Nanomaterials have already proven to be slippery
customers for regulators and regulations such as REACH,
since one chemical identity can show different physical
properties based in size and shape. Consequently the field
of particle toxicology faces a number of challenges and
opportunities in the near future. These challenges include:
- to generate understanding of the biological action of
nanomaterials
- denominate the relevant material metrics
- attract new young top researchers to the field
- Use, communicate and adapt current particle paradigms
- Bridge know-how between different application area's of
nanomaterials
- Communicate findings to the broad public in an increas-
ing relevant society
These challenges imposed by nanomaterials demand for
new collaborations between toxicologist and chemists,
material scientists, and engineers. Competence centers, or
virtual networks, where nanomaterials can be made and
tested, will be vital for further development of sustainable
nanomaterials. Particle and Fibre Toxicology wants to play a
role in this process, and has recently recruited three new
Associate Editors from China, Japan and the USA and is
still working on a complete Editorial Board setting. In
addition, we now welcome manuscripts on areas such as
biomaterials, drug delivery and imaging in an effort to bridge
the available know-how in classic particle toxicology to
these areas that have co-existed without much communi-
cation for so long.
As the new Editor-in-Chief of this journal I firmly believe
in open access publication. I also find it a privilege to con-
tribute to the development of particle toxicology as an
open access discipline for many other disciplines, in their
effort to understand the toxicological action of (nano)
materials, thereby creating a platform to help and create
sustainable materials for the future.
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